Potential skin antiinflammatory effects of 4-methylthiobutylisothiocyanate (MTBI) isolated from rocket (Eruca sativa) seeds

BioFactors

Volumn 35, Issue 3, 2009, Pages 295-305

  Yehuda, Hila ^a   Khatib, Soliman ^a,b   Sussan, Ihab ^c   Musa, Ramadan ^a   Vaya, Jacob ^a,b   Tamir, Snait ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

^c NONE

Author keywords

4 methylthiobutylisothiocyanate; Eruca sativa; Inflammation; Intercellular adhesion molecule 1; Interleukin 1 ; Interleukin 12 23p40; Isothiocyanates; Psoriasis; Rocket; Sulforaphane; Tumor necrosis factor

Indexed keywords

4 METHYLTHIOBUTYLISOTHIOCYANATE; ANTIINFLAMMATORY AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P40; ISOTHIOCYANIC ACID DERIVATIVE; MESSENGER RNA; SULFORAPHANE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4 (METHYLTHIO) 3 BUTENYL ISOTHIOCYANATE; 4-(METHYLTHIO)-3-BUTENYL ISOTHIOCYANATE; CYTOKINE; PLANT EXTRACT;

ARTICLE; CELL ACTIVATION; CELL CYCLE G2 PHASE; CELL GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; ERUCA SATIVA; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MONOCYTE; PLANT; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; BRASSICACEAE; CELL CYCLE; CELL LINE; CHEMISTRY; CYTOLOGY; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; POLYMERASE CHAIN REACTION; SKIN;

ERUCA SATIVA;

ANTI-INFLAMMATORY AGENTS; BRASSICACEAE; CELL CYCLE; CELL LINE; CHROMATOGRAPHY, LIQUID; CYTOKINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; ISOTHIOCYANATES; KERATINOCYTES; MASS SPECTROMETRY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; SKIN;

EID: 69149090771     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.32     Document Type: Article

References (48)

1. Halkier, B. A. and Gershenzon, J. (2006) Biology and biochemistry of glucosinolates. Annu. Rev. Plant. Biol. 57, 303-333.
2. Juge, N., Mithen, R. F., and Traka, M. (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol. Life Sci. 64, 1105-1127.
3. Zhang, Y., Yao, S., and Li, J. (2006) Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action. Proc. Nutr. Soc. 65 68-75.
4. Jakubikova, J., Bao, Y., and Sedlak, J. (2005) Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res. 25, 3375-3386.
5. Thejass, P. and Kuttan, G. (2007) Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide 16, 247-257.
6. Xiao, D. and Singh, S. V. (2007) Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res. 67, 2239-2246.
7. Zhang, Y., Tang, L., and Gonzalez, V. (2003) Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol. Cancer Ther. 2, 1045-1052.
8. Fimognari, C., Nusse, M., Berti, F., Iori, R., Cantelli-Forti, G., and Hrelia, P. (2004) Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non-transformed cells. Biochem. Pharmacol. 68, 1133-1138.
9. Fimognari, C., Nusse, M., Iori, R., Cantelli-Forti, G., and Hrelia, P. (2004) The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells. Invest. New Drugs 22, 119-129.
10. Lu, L., Liu, D., Ma, X., Beklemishev, A., Seiter, K., Ahmed, T., and Chiao, J. W. (2006) The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo. Oncol. Rep. 16, 1363-1367.
11. Xu, K. and Thornalley, P. J. (2000) Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem. Pharmacol. 60, 221-231.
12. Dey, M., Ribnicky, D., Kurmukov, A. G., and Raskin, I. (2006) In vitro and in vivo anti-inflammatory activity of a seed preparation containing phenethylisothiocyanate. J. Pharmacol. Exp. Ther. 317, 326-333.
13. Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., and Gerhauser, C. (2001) Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276, 32008-32015.
14. Rose, P., Won, Y. K., Ong, C. N., and Whiteman, M. (2005) Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide 12, 237-243.
15. Nakamura, Y., Miyoshi, N., Takabayashi, S., and Osawa, T. (2004) Benzyl isothiocyanate inhibits oxidative stress in mouse skin: involvement of attenuation of leukocyte infiltration. Biofactors 21, 255-257.
16. Lowes, M. A., Bowcock, A. M., and Krueger, J. G. (2007) Pathogenesis and therapy of psoriasis. Nature 445, 866-873.
17. Sabat, R., Sterry, W., Philipp, S., and Wolk, K. (2007) Three decades of psoriasis research: where has it led us? Clin. Dermatol. 25, 504-509.
18. Torti, D. C. and Feldman, S. R. (2007) Interleukin-12, interleukin-23, and psoriasis: current prospects. J. Am. Acad. Dermatol. 57, 1059-1068.
19. Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., Leong, D. U., Panko, J.M., McAllister, L. B., Hansen, C. B., Papenfuss, J., Prescott, S.M., White, T. J., Leppert, M. F., Krueger, G. G., and Begovich, A. B. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290.
20. Kimball, A. B., Gordon, K. B., Langley, R. G., Menter, A., Chartash, E. K., and Valdes, J. (2008) Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch. Dermatol. 144, 200-207.
21. Barillari, J., Canistro, D., Paolini, M., Ferroni, F., Pedulli, G. F., Iori, R., and Valgimigli, L. (2005) Direct antioxidant activity of purified glucoerucin, the dietary secondary metabolite contained in rocket (Eruca sativa Mill.) seeds and sprouts. J. Agric. Food Chem. 53, 2475-2482.
22. Fahey, J. W. and Talalay, P. (1999) Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem. Toxicol. 37, 973-979.
23. Jakubikova, J., Sedlak, J., Mithen, R., and Bao, Y. (2005) Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucininduced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem. Pharmacol. 69, 1543-1552.
24. Leoni, O., Iori, R., Palmieri, S., Esposito, E., Menegatti, E., Cortesi, R., and Nastruzzi, C. (1997) Myrosinase-generated isothiocyanate from glucosinolates: isolation, characterization and in vitro antiproliferative studies. Bioorg. Med. Chem. 5, 1799-1806.
25. Fimognari, C., Berti, F., Iori, R., Cantelli-Forti G., and Hrelia, P. Micronucleus formation and induction of apoptosis by different isothiocyanates and a mixture of isothiocyanates in human lymphocyte cultures. Mutat. Res. 582, 1-10.
26. Jakubikova, J., Sedlak, J., Bacon, J., Goldson, A., and Bao, Y. (2005) Effects of MEK1 and PI3K inhibitors on allyl-, benzyl- and phenylethylisothiocyanate-induced G2/M arrest and cell death in Caco-2 cells. Int. J. Oncol. 27, 1449-1458.
27. Azaizeh, H., Saad, B., Khalil, K., and Said, O. (2006) The state of the art of traditional arab herbal medicine in the eastern region of the mediterranean: a review. Evid. Based Complement Alternat. Med. 3, 229-235.
28. Mellon, F. A., Bennett, R. N., Holst, B., and Williamson, G. (2002) Intact glucosinolate analysis in plant extracts by programmed cone voltage electrospray LC/MS: performance and comparison with LC/MS/MS methods. Anal. Biochem. 306, 83-91.
29. Vermeulen, M., Zwanenburg, B., Chittenden, G. J., and Verhagen, H. (2003) Synthesis of isothiocyanate-derived mercapturic acids. Eur. J. Med. Chem. 38, 729-737.
30. Li, G., Tajima, H., and Ohtani, T. (1997) An improved procedure for the preparation of isothiocyanates from primary amines by using hydrogen peroxide as the dehydrosulfurization reagent. J. Org. Chem. 62, 4539-4540.
31. Becker, D. P., Flynn, D. L., Moormann, A. E., Nosal, R., Villamil, C. I., Loeffler, R., Gullikson, G. W., Moummi, C., and Yang, D. C. (2006) Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists. J. Med. Chem. 49, 1125-1139.
32. Van Ruissen, F., de Jongh, G. J., Zeeuwen, P. L., Van Erp, P. E., Madsen, P., and Schalkwijk, J. (1996) Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J. Cell. Physiol. 168, 442-452.
33. Al-Gendy, A. A. and Lockwood, G. B. (2003) GC-MS analysis of volatile hydrolysis products from glucosinolates in Farsetia aegyptia var. ovalis. Flavour Fragr. J. 18, 148-152.
34. Nickoloff, B. J. (2007) Cracking the cytokine code in psoriasis. Nat. Med. 13, 242-244.
35. Papi, A., Orlandi, M., Bartolini, G., Barillari, J., Iori, R., Paolini, M., Ferroni, F., Grazia Fumo, M., Pedulli, G. F., and Valgimigli, L. (2008) Cytotoxic and antioxidant activity of 4-methylthio-3-butenyl isothiocyanate from Raphanus sativus L. (Kaiware Daikon) sprouts. J. Agric. Food Chem. 56, 875-883.
36. Lin, W., Wu, R. T., Wu, T., Khor, T. O., Wang, H., and Kong, A. N. (2008) Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 76, 967-973.
37. Nickoloff, B. J., Bonish, B. K., Marble, D. J., Schriedel, K. A., DiPietro, L. A., Gordon, K. B., and Lingen, M. W. (2006) Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J. Investig. Dermatol. Symp. Proc. 11, 16-29.
38. Clark, R. A. and Kupper, T. S. (2006) Misbehaving macrophages in the pathogenesis of psoriasis. J. Clin. Invest. 116, 2084-2087.
39. Tada, Y., Asahina, A., Takekoshi, T., Kishimoto, E., Mitsui, H., Saeki, H., Komine, M., and Tamaki, K. (2006) Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by ciclosporin A. Br. J. Dermatol. 154, 1180-1183.
40. Wang, H., Peters, T., Kess, D., Sindrilaru, A., Oreshkova, T., Van Rooijen, N., Stratis, A., Renkl, A. C., Sunderkotter, C., Wlaschek, M., Haase, I., and Scharffetter-Kochanek, K. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116, 2105-2114.
41. Nishibori, M., Takahashi, H. K., and Mori, S. (2003) The regulation of ICAM-1 and LFA-1 interaction by autacoids and statins: a novel strategy for controlling inflammation and immune responses. J. Pharmacol. Sci. 92, 7-12.
42. Liu, Y. C., Hsieh, C. W., Weng, Y. C., Chuang, S. H., Hsieh, C. Y., and Wung, B. S. (2008) Sulforaphane inhibition of monocyte adhesion via the suppression of ICAM-1 and NF-kappaB is dependent upon glutathione depletion in endothelial cells. Vascul. Pharmacol. 48, 54-61.
43. Simmons, D. L. (2005) Anti-adhesion therapies. Curr. Opin. Pharmacol. 5, 398-404.
44. Stratis, A., Pasparakis, M., Rupec, R. A., Markur, D., Hartmann, K., K.Scharffetter-Kochanek, Peters, T., van Rooijen, N., Krieg, T., and Haase, I. (2006) Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J. Clin. Invest. 116, 2094-2104.
45. Wang, F., Lee, E., Lowes, M. A., Haider, A. S., Fuentes-Duculan, J., Abello, M. V., Chamian, F., Cardinale, I., and Krueger, J. G. (2006) Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. J. Invest. Dermatol. 126, 1590-1599.
46. Grether-Beck, S., Felsner, I., Brenden, H., and Krutmann, J. (2003) Mitochondrial cytochrome c release mediates ceramide-induced activator protein 2 activation and gene expression in keratinocytes. J. Biol. Chem. 278, 47498-47507.
47. Hida, N., Shimoyama, T., Jr., Neville, P., Dixon, M. F., Axon, A. T., Shimoyama, T., Sr., and Crabtree, J. E. (1999) Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J. Clin. Pathol. 52, 658-664.
48. Lichtenstein, M., Zimran, A., and Horowitz, M. (1997) Cytokine mRNA in Gaucher disease. Blood Cells Mol. Dis. 23, 395-401.